Text Correction
There was an error in the original article [1]. In the Abstract, page 1, line 12 from the top, the sentence “… remdesivir, a nucleotide analog that acts as reverse-transcriptase inhibitor, …” is incorrect.
A correction has been made to the Abstract.
The incorrect sentence must be replaced with “… remdesivir, a nucleotide analog that acts as RNA-dependent RNA-polymerase inhibitor, …”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Zanella I., Zizioli D., Castelli F., Quiros-Roldan E. Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV-2 infection. Pharmaceuticals. 2021;14:454. doi: 10.3390/ph14050454. [DOI] [PMC free article] [PubMed] [Google Scholar]